Atlas Private Wealth Advisors Eli Lilly & CO Transaction History
Atlas Private Wealth Advisors
- $731 Million
- Q2 2025
A detailed history of Atlas Private Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Atlas Private Wealth Advisors holds 284 shares of LLY stock, worth $182,004. This represents 0.03% of its overall portfolio holdings.
Number of Shares
284Holding current value
$182,004% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,399Shares Held
807MCall Options Held
9.9MPut Options Held
10.9M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$64.9 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$61.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$50.8 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$42.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$22.1 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $609B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...